Meta-Analysis of Randomized Controlled Trials on the Efficacy of Di’ao Xinxuekang Capsule and Isosorbide Dinitrate in Treating Angina Pectoris

Table 1

Summary of the included studies evaluating the efficacy of XXK in treating angina pectoris.

Study	No. of authors	Trail date	Sample size	Follow-up period	Comparable	AEs	Outcome measures	XXK daily dosage	ISDN daily dosage	Jadad score	M score
Zeng et al. [29]	6	0	34	28 days	1	1	SYM, ECG	6 pills	40 mg	2	4
Dai [30]	1	1	120	28 days	0	0	SYM	6 pills	30 mg	2	2
Hu [31]	1	0	84	28 days	1	1	SYM, ECG	6 pills	30 mg	2	4
Li and Zhang [34]	2	1	60	28 days	0	1	SYM	6 pills	60 mg	2	3
Qu [32]	1	1	60	28 days	1	0	SYM, ECG	6 pills	30 mg	2	3
Shen [33]	1	1	132	28 days	0	1	SYM, ECG	6 pills	30 mg	2	3
Zhu et al. [35]	5	1	60	28 days	1	0	SYM, ECG	6 pills	30 mg	2	3

XXK is di’ao xinxuekang capsule; ISDN is isosorbide dinitrate; SYM is SYMPTOMS; ECG is electrocardiogram; AEs is adverse events; Numbers 1 and 0 in “Trial date” mean that study reported or did not report the trial date, respectively; Numbers 1 and 0 in “Comparable” mean that the study reported the comparability between the experiment and control groups (1) or the study did not report that (0).